Ob/Gyn Articles

Ob/Gyn

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tamoxifen is a widely used and highly successful drug in the treatment of breast cancer, though resistance to tamoxifen is still a concern in recurrent disease (affecting 25-35% of patients), since therapy resistant metastatic tumor cells are a major cause of death. Researchers have uncovered a protein profile that may accurately predict whether a cancer will be tamoxifen resistant.

   

Today in Popular Press...keeping you current

Stratifying breast cancer without biopsy: Researchers identify possible imaging method
ScienceDaily, 12/18/09

Breakthrough May Pave the Way for Therapeutic Vaccines
ScienceDaily, 12/18/09

Negative emotions outweigh intent to exercise at health clubs
ScienceDaily, 12/18/09